Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostacyclin for acute coronary insufficiency.

A Szczeklik, J Szczeklik, R Nizankowski

    Artery
    |January 1, 1980
    PubMed
    Summary

    Prostacyclin (PGI2) infusions did not prevent effort angina but improved spontaneous angina at rest. PGI2 may benefit angina caused by reduced oxygen delivery, not increased demand.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical characteristics of Polish patients with ANCA-associated vasculitides-retrospective analysis of POLVAS registry.

    Clinical rheumatology·2019
    Same author

    Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
    Same author

    Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs.

    Allergy·2013
    Same author

    Antibodies to N-homocysteinylated albumin and haemoglobin in patients with rheumatoid arthritis: a potential new marker of disease severity.

    Scandinavian journal of rheumatology·2013
    Same author

    Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

    The Journal of allergy and clinical immunology·2012
    Same author

    12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012

    Area of Science:

    • Cardiology
    • Pharmacology
    • Internal Medicine

    Background:

    • Angina pectoris is a condition characterized by chest pain due to myocardial ischemia.
    • Two main types, effort angina and spontaneous angina, may have different underlying pathophysiological mechanisms.
    • Prostacyclin (PGI2) is a vasodilator with potential anti-anginal properties.

    Purpose of the Study:

    • To investigate the efficacy of prostacyclin (PGI2) in managing two distinct types of angina pectoris: effort-induced and spontaneous.
    • To compare the effects of PGI2 with sublingual nitroglycerin in effort angina.
    • To determine if PGI2 could offer therapeutic benefits in angina precipitated by reduced oxygen supply versus increased oxygen demand.

    Main Methods:

    • Intravenous infusions of prostacyclin (PGI2) at doses of 5 or 10 ng/kg/min were administered.
    • Effort angina was studied using atrial pacing as a provocation method.
    • Spontaneous angina attacks at rest were monitored for changes during PGI2 infusion.

    Main Results:

    • Prostacyclin infusions (5 or 10 ng/kg/min) provided no protection against effort angina attacks induced by atrial pacing.
    • In contrast, PGI2 infusion at 5 ng/kg/min resulted in sustained improvement for spontaneous angina at rest.
    • Patients experienced a reduction in anginal attacks and nitroglycerin usage during PGI2 treatment for spontaneous angina.

    Conclusions:

    • The differential effects of prostacyclin suggest distinct pathogenic mechanisms for effort and spontaneous angina.
    • Prostacyclin (PGI2) may hold therapeutic value for angina pectoris resulting from reduced myocardial oxygen delivery.
    • PGI2 appears less effective when angina is primarily driven by increased myocardial oxygen demand.

    Related Experiment Videos